Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

394 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Development and external validation of a nomogram for overall survival after curative resection in serosa-negative, locally advanced gastric cancer.
Hirabayashi S, Kosugi S, Isobe Y, Nashimoto A, Oda I, Hayashi K, Miyashiro I, Tsujitani S, Kodera Y, Seto Y, Furukawa H, Ono H, Tanabe S, Kaminishi M, Nunobe S, Fukagawa T, Matsuo R, Nagai T, Katai H, Wakai T, Akazawa K. Hirabayashi S, et al. Ann Oncol. 2014 Jun;25(6):1179-84. doi: 10.1093/annonc/mdu125. Epub 2014 Mar 24. Ann Oncol. 2014. PMID: 24669009 Free article.
Gastric cancer treated by endoscopic submucosal dissection or endoscopic mucosal resection in Japan from 2004 through 2006: JGCA nationwide registry conducted in 2013.
Tanabe S, Hirabayashi S, Oda I, Ono H, Nashimoto A, Isobe Y, Miyashiro I, Tsujitani S, Seto Y, Fukagawa T, Nunobe S, Furukawa H, Kodera Y, Kaminishi M, Katai H. Tanabe S, et al. Among authors: hirabayashi s. Gastric Cancer. 2017 Sep;20(5):834-842. doi: 10.1007/s10120-017-0699-4. Epub 2017 Feb 15. Gastric Cancer. 2017. PMID: 28205058
The impacts of BCR-ABL1 mutations in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia who underwent allogeneic hematopoietic cell transplantation.
Tachibana T, Najima Y, Akahoshi Y, Hirabayashi S, Harada K, Doki N, Uchida N, Fukuda T, Sawa M, Ogata M, Takada S, Tanaka M, Matsuhashi Y, Tanaka J, Onizuka M, Ichinohe T, Atsuta Y, Kako S; Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation. Tachibana T, et al. Among authors: hirabayashi s. Ann Hematol. 2020 Oct;99(10):2393-2404. doi: 10.1007/s00277-020-04212-1. Epub 2020 Aug 15. Ann Hematol. 2020. PMID: 32803312
Individual HLAs influence immunological events in allogeneic stem cell transplantation from HLA-identical sibling donors.
Morishima S, Fukuda T, Doki N, Mori T, Onizuka M, Kawakita T, Kato C, Ozawa Y, Tanaka M, Kurokawa M, Kamimura T, Inoue M, Tanaka J, Ichinohe T, Atsuta Y, Morishima Y; HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation. Morishima S, et al. Bone Marrow Transplant. 2021 Mar;56(3):646-654. doi: 10.1038/s41409-020-01070-3. Epub 2020 Oct 9. Bone Marrow Transplant. 2021. PMID: 33037403
Measurable residual disease affects allogeneic hematopoietic cell transplantation in Ph+ ALL during both CR1 and CR2.
Nishiwaki S, Akahoshi Y, Mizuta S, Shinohara A, Hirabayashi S, Noguchi Y, Fukuda T, Uchida N, Tanaka M, Onizuka M, Ozawa Y, Ota S, Shiratori S, Onishi Y, Kanda Y, Sawa M, Tanaka J, Atsuta Y, Kako S. Nishiwaki S, et al. Among authors: hirabayashi s. Blood Adv. 2021 Jan 26;5(2):584-592. doi: 10.1182/bloodadvances.2020003536. Blood Adv. 2021. PMID: 33496752 Free PMC article.
Comparison of fludarabine, a myeloablative dose of busulfan, and melphalan vs conventional myeloablative conditioning regimen in patients with relapse and refractory acute myeloid leukemia in non-remission status.
Shimomura Y, Hara M, Hirabayashi S, Kondo T, Mizuno S, Uchida N, Mukae J, Kawakita T, Fukuda T, Kanda Y, Ota S, Ozawa Y, Eto T, Maruyama Y, Tanaka M, Nakano N, Kimura T, Ichinohe T, Atsuta Y, Yanada M. Shimomura Y, et al. Among authors: hirabayashi s. Bone Marrow Transplant. 2021 Sep;56(9):2302-2304. doi: 10.1038/s41409-021-01380-0. Epub 2021 Jun 21. Bone Marrow Transplant. 2021. PMID: 34155357 No abstract available.
Differential Effect of Graft-versus-Host Disease on Survival in Acute Leukemia according to Donor Type.
Konuma T, Kanda J, Kuwatsuka Y, Yanada M, Kondo T, Hirabayashi S, Kako S, Akahoshi Y, Uchida N, Doki N, Ozawa Y, Tanaka M, Eto T, Sawa M, Yoshioka S, Kimura T, Kanda Y, Fukuda T, Atsuta Y, Kimura F. Konuma T, et al. Among authors: hirabayashi s. Clin Cancer Res. 2021 Sep 1;27(17):4825-4835. doi: 10.1158/1078-0432.CCR-20-4856. Epub 2021 Jun 22. Clin Cancer Res. 2021. PMID: 34158357
Residual disease is a strong prognostic marker in patients with acute lymphoblastic leukaemia with chemotherapy-refractory or relapsed disease prior to allogeneic stem cell transplantation.
Nakamura M, Arai Y, Hirabayashi S, Kondo T, Doki N, Uchida N, Fukuda T, Ozawa Y, Tanaka M, Sawa M, Katayama Y, Kanda Y, Shiratori S, Nakamae H, Yoshioka S, Onizuka M, Ichinohe T, Atsuta Y, Kako S. Nakamura M, et al. Among authors: hirabayashi s. Br J Haematol. 2021 Jul;194(2):403-413. doi: 10.1111/bjh.17646. Epub 2021 Jun 22. Br J Haematol. 2021. PMID: 34159580 Free article.
394 results